The Impact of HIV Infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Patients with Breast Cancer.
Daniel S O'NeilOluwatosin A AyeniHayley A FarrowWenlong Carl ChenGeorgia DemetriouInes BuccimazzaSharon ČačalaLaura W StopforthMaureen JoffeMichael H AntoniGilberto LopesYoanna S PumpalovaWitness MapangaJudith S JacobsonKatherine D CrewAlfred I NeugutPaul RuffHerbert CubaschPublished in: The oncologist (2023)
HIV status did not impact neoadjuvant or adjuvant chemotherapy RDI, although patients with breast cancer living with HIV experienced more myelotoxicity during treatment.